Profile picture

Doctor David Fitchett

St. Michael's Hospital, Toronto (Canada)
Membership: FESC Member
Follow
Logo ESC

Contributor content

Modern management of diabetes in cardiology: impact of SGLT2 inhibition on cardiovascular outcomes and heart failure (EBAC Accredited)
Session
Modern management of diabetes in cardiology: impact of SGLT2 inhibition on cardiovascular outcomes and heart failure (EBAC Accredited)
28 August 2017
Read more
SGLT2 inhibition in diabetes and heart failure: discuss the evidence
Session
SGLT2 inhibition in diabetes and heart failure: discuss the evidence
29 August 2016
Read more
SGLT2 inhibition, diabetes and CVD: where does this fit in CV risk management?
Session
SGLT2 inhibition, diabetes and CVD: where does this fit in CV risk management?
28 August 2016
Read more

ESC 365 is supported by

novartis Explore sponsored resources